Emulsomes meet S-layer proteins: an emerging targeted drug delivery system
- PMID: 25697368
- PMCID: PMC4460288
- DOI: 10.2174/138920101604150218112656
Emulsomes meet S-layer proteins: an emerging targeted drug delivery system
Abstract
Here, the use of emulsomes as a drug delivery system is reviewed and compared with other similar lipidic nanoformulations. In particular, we look at surface modification of emulsomes using S-layer proteins, which are self-assembling proteins that cover the surface of many prokaryotic organisms. It has been shown that covering emulsomes with a crystalline S-layer lattice can protect cells from oxidative stress and membrane damage. In the future, the capability to recrystallize S-layer fusion proteins on lipidic nanoformulations may allow the presentation of binding functions or homing protein domains to achieve highly specific targeted delivery of drug-loaded emulsomes. Besides the discussion on several designs and advantages of composite emulsomes, the success of emulsomes for the delivery of drugs to fight against viral and fungal infections, dermal therapy, cancer, and autoimmunity is summarized. Further research might lead to smart, biocompatible emulsomes, which are able to protect and reduce the side effects caused by the drug, but at the same time are equipped with specific targeting molecules to find the desired site of action.
Figures
References
-
- Amselem AS, Yogev A, Zawoznik E, Friedman D. In Emulsomes, A Novel Drug Delivery Technology. International Symposium on the Control and Release of Bioactive Materials. 1994:1369.
-
- Amselem A S, Zawoznik E, Yogev A, Friedman D. Emulsomes, a new type of lipid assembly Handbook of Nonmedical Applications of Liposomes. In: Barenholz Y, Lasic D D, editors; III. Florida: CRC Press:; 1996. pp. 209–223.
-
- Vyas SP, Subhedar R, Jain S. Development and characterization of emulsomes for sustained and targeted delivery of an anti-viral agent to liver. J. Pharm. Pharmacol. 2006;58(3 ):321–326. - PubMed
-
- Amselem AS, Friedman D. Solid fat nanoemulsions. United States Patent No. 5662932 02.09. 1997 2.09
-
- Pal A, Gupta S, Jaiswal A, Dube A, Vyas SP. Development and evaluation of tripalmitin emulsomes for the treatment of experimental visceral leishmaniasis. J. Liposome Res. 2012;22(1 ):62–71. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
